Literature DB >> 26659376

Comparison of Atherosclerotic Calcification in Major Vessel Beds on the Risk of All-Cause and Cause-Specific Mortality: The Rotterdam Study.

Daniel Bos1, Maarten J G Leening1, Maryam Kavousi1, Albert Hofman1, Oscar H Franco1, Aad van der Lugt1, Meike W Vernooij1, M Arfan Ikram2.   

Abstract

BACKGROUND: Atherosclerosis is a major contributor to global morbidity and mortality. Although atherosclerosis is a systemic disease, its burden varies considerably across vessel beds, which may translate into differences in mortality risk. METHODS AND
RESULTS: From 2003 to 2006, a sample of 2408 elderly participants (mean age, 69.6±6.7 years; 52.4% female) from the population-based Rotterdam Study underwent computed tomography to quantify atherosclerotic calcification in the coronary arteries, aortic arch, extracranial, and intracranial internal carotid arteries. Mortality follow-up was complete until January 1, 2012. We investigated associations of calcification in each vessel bed with mortality using Cox regression, adjusting for age, sex, and cardiovascular risk factors. Next, all vessel beds were included into 1 model to investigate independency of associations. Finally, we investigated the predictive value of calcification beyond the predictors included in the Pooled Cohort equations. During 15 775 person-years of follow-up, 283 participants died. Larger calcification volumes in all vessels were related to higher risks of all-cause mortality, cardiovascular, and noncardiovascular mortality, independent of cardiovascular risk factors. Most prominent associations were found for aortic arch calcification and cardiovascular mortality (age- and sex-adjusted hazard ratio per 1-SD increase 2.72 [95% confidence interval, 1.85-4.02]), independent of calcification elsewhere (hazard ratio, 1.75 (95% confidence interval, 1.13-2.72]). Calcification in any vessel improved prediction for all 3 outcomes.
CONCLUSIONS: Atherosclerotic load in major vessel beds is associated with an increased risk of death. In particular, aortic arch calcification volume yields unique information with regard to mortality in addition to atherosclerosis in other vessel beds.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular disease; computed tomography; epidemiology; mortality; risk factors

Mesh:

Year:  2015        PMID: 26659376     DOI: 10.1161/CIRCIMAGING.115.003843

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  32 in total

1.  Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.

Authors:  M Kyla Shea; Kathryn Barger; Sarah L Booth; Gregory Matuszek; Mary Cushman; Emelia J Benjamin; Stephen B Kritchevsky; Daniel E Weiner
Journal:  Am J Clin Nutr       Date:  2020-06-01       Impact factor: 7.045

2.  Thoracic Aorta Calcification and Noncardiovascular Disease-Related Mortality.

Authors:  Isac C Thomas; Caroline A Thompson; Mingan Yang; Matthew A Allison; Nketi I Forbang; Erin D Michos; Robyn L McClelland; Matthew J Budoff; Michael H Criqui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

3.  The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Angelica Ezeigwe; Oluwaseun E Fashanu; Di Zhao; Matthew J Budoff; James D Otvos; Isac C Thomas; Samia Mora; Martin Tibuakuu; Erin D Michos
Journal:  Atherosclerosis       Date:  2019-01-24       Impact factor: 5.162

4.  Density of calcium in the ascending thoracic aorta and risk of incident cardiovascular disease events.

Authors:  Isac C Thomas; Robyn L McClelland; Erin D Michos; Matthew A Allison; Nketi I Forbang; W T Longstreth; Wendy S Post; Nathan D Wong; Matthew J Budoff; Michael H Criqui
Journal:  Atherosclerosis       Date:  2017-09-07       Impact factor: 5.162

Review 5.  Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease.

Authors:  Manus J Donahue; Eric Achten; Petrice M Cogswell; Frank-Erik De Leeuw; Colin P Derdeyn; Rick M Dijkhuizen; Audrey P Fan; Rashid Ghaznawi; Jeremy J Heit; M Arfan Ikram; Peter Jezzard; Lori C Jordan; Eric Jouvent; Linda Knutsson; Richard Leigh; David S Liebeskind; Weili Lin; Thomas W Okell; Adnan I Qureshi; Charlotte J Stagg; Matthias Jp van Osch; Peter Cm van Zijl; Jennifer M Watchmaker; Max Wintermark; Ona Wu; Greg Zaharchuk; Jinyuan Zhou; Jeroen Hendrikse
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

6.  Associations between hip bone mineral density, aortic calcification and cardiac workload in community-dwelling older Australians.

Authors:  A J Rodríguez; D Scott; A Hodge; D R English; G G Giles; P R Ebeling
Journal:  Osteoporos Int       Date:  2017-04-04       Impact factor: 4.507

7.  Associations of endogenous sex hormone levels with the prevalence and progression of valvular and thoracic aortic calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Apurva Sharma; Oluseye Ogunmoroti; Oluwaseun E Fashanu; Di Zhao; Pamela Ouyang; Matthew J Budoff; Isac C Thomas; Erin D Michos
Journal:  Atherosclerosis       Date:  2021-11-10       Impact factor: 5.162

8.  Molecular Imaging of Atherosclerosis: A Clinical Focus.

Authors:  Mohammed M Chowdhury; Ahmed Tawakol; Farouc A Jaffer
Journal:  Curr Cardiovasc Imaging Rep       Date:  2017-02-04

9.  Aortic Atheroma Increases the Risk of Long-Term Mortality in 20,000 Patients.

Authors:  Carolyn Goldberg Butler; Jamahal Maeng Ho Luxford; Chuan-Chin Huang; Julius I Ejiofor; James D Rawn; Kerry Wilusz; John A Fox; Stanton K Shernan; Jochen Daniel Muehlschlegel
Journal:  Ann Thorac Surg       Date:  2017-06-01       Impact factor: 4.330

Review 10.  Perspective: Evidence before Enthusiasm-A Critical Review of the Potential Cardiovascular Benefits of Vitamin K.

Authors:  M Kyla Shea; Kathleen L Berkner; Guylaine Ferland; Xueyan Fu; Rachel M Holden; Sarah L Booth
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.